The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication
Open accessAbstract
AIM: To determine the incidence of ocular toxicity of preservatives with glaucoma medications. METHODS: A prospective epidemiological survey was carried out in 1999 by 249 ophthalmologists on 4107 patients. Ocular symptoms, conjunctiva, cornea, and eyelids were assessed. A chi(2) test was used for differences between preserved eye drops (P) and preservative free eye drops (PF). RESULTS: 84% patients used P, 13% received PF, and 3% a combination of P and PF eye drops. All symptoms were more prevalent with P than with PF drops (p<0.001): discomfort upon instillation (43% versus 17%), and symptoms between instillations such as burning-stinging (40% versus 22%), foreign body sensation (31% versus 14%), dry eye sensation (23% versus 14%), tearing (21% versus 14%), and eyelid itching (18% versus 10%). An increased incidence (>2 times) of ocular signs was seen with P eye drops. The prevalence of signs and symptoms was dose dependent, increasing with the number of P drops. A reduction in the symptoms and signs was observed when patients changed from P to PF eye drops (p<0.001). CONCLUSIONS: Symptoms and signs are less prevalent when PF drops are used. Moreover, most of the adverse reactions induced by P glaucoma medication are reversible after removing preservatives.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells.
Jean, M. D. S., Brignole‐Baudouin, F., Bringuier, A. F., Bauchet, A.-L., Feldmann, G., & Baudouin, C. (1999) · PubMed · Cited by 317
Effect of benzalkonium chloride on the stability of the precorneal tear film in rabbit and man.
Wilson, W. S., Duncan, A. J., & Jay, J. L. (1975) · British Journal of Ophthalmology · doi:10.1136/bjo.59.11.667 · Cited by 177
Burstein, N. L. (1980) · PubMed · Cited by 175
De Saint Jean, M., Debbasch, C., Brignole, F., Rat, P., Warnet, J.-M., & Baudouin, C. (2000) · Current Eye Research · doi:10.1076/0271-3683(200002)2021-dft085 · Cited by 172
The effects of topical drugs and preservatives on the tears and corneal epithelium in dry eye.
Burstein, N. L. (1985) · PubMed · Cited by 101
Brignole‐Baudouin, F., Jean, M. D. S., Goldschild, M., Becquet, F., Goguel, A., & Baudouin, C. (1998) · Experimental Eye Research · doi:10.1006/exer.1998.0566 · Cited by 79
Expression of CD40 and CD40 ligand in the human conjunctival epithelium.
Bourcier, T., Jean, M. D. S., Brignole‐Baudouin, F., Goguel, A. F., & Baudouin, C. (2000) · PubMed · Cited by 45
Effects of Antiglaucoma Medications on Bovine Trabecular Meshwork Cells In Vitro
Kawa, J. E., Higginbotham, E. J., Chang, I. L., & Yue, B. Y. J. T. (1993) · Experimental Eye Research · doi:10.1006/exer.1993.1160 · Cited by 30
Cited by
(2007) · The Ocular Surface · doi:10.1016/s1542-0124(12)70081-2 · Cited by 3,267
TFOS DEWS II Diagnostic Methodology report
Wolffsohn, J. S., Arita, R., Chalmers, R., Djalilian, A., Dogru, M., Dumbleton, K., Gupta, P. K., Karpecki, P., Lazreg, S., Pult, H., et al. (2017) · The Ocular Surface · doi:10.1016/j.jtos.2017.05.001 · Cited by 2,122
TFOS DEWS II Management and Therapy Report
Jones, L., Downie, L. E., Korb, D., Benitez-del-Castillo, J. M., Dana, R., Deng, S. X., Dong, P. N., Geerling, G., Hida, R. Y., Liu, Y., et al. (2017) · The Ocular Surface · doi:10.1016/j.jtos.2017.05.006 · Cited by 1,422
Preservatives in eyedrops: The good, the bad and the ugly
Baudouin, C., Labbé, A., Liang, H., Pauly, A., & Brignole-Baudouin, F. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.03.001 · Cited by 1,084
Baudouin, C., Messmer, E. M., Aragona, P., Geerling, G., Akova, Y. A., Benítez-del-Castillo, J., Boboridis, K. G., Merayo-Lloves, J., Rolando, M., & Labetoulle, M. (2016) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2015-307415 · Cited by 516
TFOS DEWS II iatrogenic report
Gomes, J. A. P., Azar, D. T., Baudouin, C., Efron, N., Hirayama, M., Horwath-Winter, J., Kim, T., Mehta, J. S., Messmer, E. M., Pepose, J. S., et al. (2017) · The Ocular Surface · doi:10.1016/j.jtos.2017.05.004 · Cited by 462
Pisella, P.-J. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-1067 · Cited by 287
Self-citation(2017) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2016-egsguideline.003 · Cited by 268
Ocular Surface Disease and Quality of Life in Patients With Glaucoma
Skalicky, S. E., Goldberg, I., & McCluskey, P. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2011.05.033 · Cited by 254
Tseng, C.-L., Hung, Y.-J., Chen, Z.-Y., Fang, H.-W., & Chen, K.-H. (2016) · PLOS ONE · doi:10.1371/journal.pone.0157982 · Cited by 53
Halder, A., & Khopade, A. J. (2020) · Clinical ophthalmology · doi:10.2147/opth.s266453 · Cited by 12
Metadata
- Authors
- Pisella, P. J.
- Venue
- British Journal of Ophthalmology
- Publisher
- BMJ
- Published
- 2002-04-01
- Volume
- 86
- Issue
- 4
- Pages
- 418-423
- ISSN
- 0007-1161 (ISSN-L)
- OpenAlex
- W2162316179
- Cited by
- 618
- References
- 8
- FWCI
- 5.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.